UltraCor Twirl Breast Tissue Marker
Marker, Radiographic, Implantable. 510(k) K152510, from Bard Peripheral Vascular, Inc. (Tempe, AZ). Product code NEU, class 2.
As of Nov 21, 2026, K152510 is an FDA 510(k) held by Bard Peripheral Vascular, Inc., substantially equivalent on May 13, 2016 after 254 days, with no recalls tied to it in FDA's recall database.
- Review time: 254 days
- Recalls: 0
- Cited as a predicate by: 1 device
The UltraCor Twirl Breast Tissue Marker is intended for use to attach to soft breast tissue at the surgical site during an open surgical breast biopsy or a percutaneous breast biopsy to radiographically mark the location of the biopsy procedure.
- Ultraclip Ii US Wing and Coil, Models: 862017U, 864017UK090547 · C.R. Bard, Inc. · Mar 18, 2009
- UltraCor Twirl Breast Tissue MarkerK180061 · Bard Peripheral Vascular, Inc. · Mar 9, 2018
- HydroMARK™ Plus Breast Biopsy Site Marker (Dragonfly Shape); HydroMARK™ Plus Breast Biopsy Site Marker (Hummingbird…K253761 · Devicor Medical Products, Inc. · Jan 23, 2026
- MOLLI 2 SystemK253888 · Stryker Endoscopy · Dec 31, 2025
- SCOUT MD Surgical Guidance SystemK252892 · Merit Medical Systems, Inc. · Dec 19, 2025
- VizMark Preloaded Tissue Marker Device (VM-0001)K251989 · Breast-Med, Inc. · Dec 12, 2025
- MammoSTAR Biopsy Site IdentifierK251748 · Carbon Medical Technologies, Inc. · Jul 23, 2025
- UltraCor™ Twirl™ Breast Tissue MarkerK243642 · Bard Peripheral Vascular, Inc. · Mar 24, 2025
- SmartClip Secure Soft Tissue MarkerK233639 · Elucent Medical, Inc. · Dec 20, 2024
- Trilogy Tissue MarkerK240429 · Inrad, Inc. · Nov 7, 2024
- Document
- 510(k) summary (PDF) ↗
- Type
- Traditional
- Received
- Sep 2, 2015
- Review panel
- General, Plastic Surgery
- Regulation
- 21 CFR 878.4300
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files